back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-12-27 Tx date 2018-12-26 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,119
-1,200 vol $0.93 each |
1,946,954 | |
| Filed 2018-12-27 Tx date 2018-12-24 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-392.00
-400 vol $0.98 each |
1,948,154 | |
| Filed 2018-12-27 Tx date 2018-12-26 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,446.908
-83,245 vol $0.98 each |
1,863,709 | |
| Filed 2018-08-14 Tx date 2018-08-09 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
70 - Acquisition or disposition (writing) of third party derivative
|
$-3.33
-1 vol $3.33 each |
0 | |
| Filed 2018-08-14 Tx date 2018-08-09 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
70 - Acquisition or disposition (writing) of third party derivative
|
$3.33
+1 vol $3.33 each |
1 | |
| Filed 2018-08-14 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-14 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-14 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-14 Tx date 2018-08-09 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,300
+10,000 vol $3.33 each |
19,600 | |
| Filed 2018-03-16 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-15 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+909,296 vol |
909,296 | |
| Filed 2017-01-17 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
70 - Acquisition or disposition (writing) of third party derivative
|
$8.65
+1 vol $8.65 each |
1 | |
| Filed 2017-01-17 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
70 - Acquisition or disposition (writing) of third party derivative
|
$-8.65
-1 vol $8.65 each |
0 | |
| Filed 2017-01-13 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Assignment Agreement
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
37 - Stock split or consolidation
|
-6,488,592 vol |
||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-7,794,216 vol |
1,948,554 | |
| Filed 2016-12-27 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$83,040
+9,600 vol $8.65 each |
9,600 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,600 vol |
||
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,600 vol |
||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
37 - Stock split or consolidation
|
-6,488,592 vol |
||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
37 - Stock split or consolidation
|
-6,488,592 vol |
1,622,148 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
37 - Stock split or consolidation
|
-6,488,592 vol |
1,622,148 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Fully Paid Warrant
37 - Stock split or consolidation
|
-2,272,728 vol |
568,181 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,269,831 | ||
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Fully Paid Warrant
16 - Acquisition or disposition under a prospectus exemption
|
+2,840,909 vol |
2,840,909 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Fully Paid Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
16 - Acquisition or disposition under a prospectus exemption
|
+2,840,909 vol |
8,110,740 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-23 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
35 - Stock dividend
|
+5,269,831 vol |
5,269,831 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
16 - Acquisition or disposition under a prospectus exemption
|
+2,840,909 vol |
8,110,740 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-23 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
35 - Stock dividend
|
+5,269,831 vol |
5,269,831 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Kotler, Kevin
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Broadfin Health Care Master Fund, Ltd. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+4,472,939 vol |
9,742,770 |